242 related articles for article (PubMed ID: 23278403)
21. Detection of ligand-selective interactions of the human androgen receptor by SELDI-MS-TOF.
Linke T; Scholten M; Baniahmad A
Methods Mol Biol; 2011; 776():225-51. PubMed ID: 21796530
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel androgen receptor degrading agents to treat advanced prostate cancer.
Wu H; Ren J; Zhao L; Li Z; Ye W; Yang Y; Wang J; Bian J
Eur J Med Chem; 2021 May; 217():113376. PubMed ID: 33756125
[TBL] [Abstract][Full Text] [Related]
23. Conformational dynamics of androgen receptors bound to agonists and antagonists.
Gim HJ; Park J; Jung ME; Houk KN
Sci Rep; 2021 Aug; 11(1):15887. PubMed ID: 34354111
[TBL] [Abstract][Full Text] [Related]
24. Preliminary investigations into triazole derived androgen receptor antagonists.
Altimari JM; Niranjan B; Risbridger GP; Schweiker SS; Lohning AE; Henderson LC
Bioorg Med Chem; 2014 May; 22(9):2692-706. PubMed ID: 24726305
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of novel thiazole-based derivatives as selective inhibitors of DNA-binding domain of the androgen receptor.
Xu R; Tian Y; Huang S; Yu J; Deng Y; Zhan M; Zhang T; Wang F; Zhao L; Chen Y
Chem Biol Drug Des; 2018 Jan; 91(1):172-180. PubMed ID: 28667662
[TBL] [Abstract][Full Text] [Related]
26. Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist.
Wu M; Xie Y; Cui X; Huang C; Zhang R; He Y; Li X; Liu M; Cen S; Zhou J
Eur J Med Chem; 2019 Mar; 166():232-242. PubMed ID: 30711833
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators.
Sundén H; Holland MC; Poutiainen PK; Jääskeläinen T; Pulkkinen JT; Palvimo JJ; Olsson R
J Med Chem; 2015 Feb; 58(3):1569-74. PubMed ID: 25646649
[TBL] [Abstract][Full Text] [Related]
28. Identification of a group of brominated flame retardants as novel androgen receptor antagonists and potential neuronal and endocrine disrupters.
Kharlyngdoh JB; Pradhan A; Asnake S; Walstad A; Ivarsson P; Olsson PE
Environ Int; 2015 Jan; 74():60-70. PubMed ID: 25454221
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
[TBL] [Abstract][Full Text] [Related]
30. The systematic structure-activity relationship to predict how flavones bind to human androgen receptor for their antagonistic activity.
Tamura H; Yoshioka M; Hasegawa M; Hosoda A; Matsugi M; Akamatsu M
Bioorg Med Chem; 2013 Jun; 21(11):2968-74. PubMed ID: 23611768
[TBL] [Abstract][Full Text] [Related]
31. Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens.
Bobach C; Tennstedt S; Palberg K; Denkert A; Brandt W; de Meijere A; Seliger B; Wessjohann LA
Eur J Med Chem; 2015 Jan; 90():267-79. PubMed ID: 25461327
[TBL] [Abstract][Full Text] [Related]
32. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
Fousteris MA; Schubert U; Roell D; Roediger J; Bailis N; Nikolaropoulos SS; Baniahmad A; Giannis A
Bioorg Med Chem; 2010 Oct; 18(19):6960-9. PubMed ID: 20826091
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
[TBL] [Abstract][Full Text] [Related]
34. Structure-based virtual screening and identification of a novel androgen receptor antagonist.
Song CH; Yang SH; Park E; Cho SH; Gong EY; Khadka DB; Cho WJ; Lee K
J Biol Chem; 2012 Aug; 287(36):30769-80. PubMed ID: 22798067
[TBL] [Abstract][Full Text] [Related]
35. Novel androgen receptor antagonist identified by structure-based virtual screening, structural optimization, and biological evaluation.
Tang Q; Fu W; Zhang M; Wang E; Shan L; Chai X; Pang J; Wang X; Xu X; Xu L; Li D; Sheng R; Hou T
Eur J Med Chem; 2020 Apr; 192():112156. PubMed ID: 32114360
[TBL] [Abstract][Full Text] [Related]
36. Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; in silico and in vitro.
Singh P; Bast F
Invest New Drugs; 2015 Jun; 33(3):575-93. PubMed ID: 25895100
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer.
Li H; Hassona MD; Lack NA; Axerio-Cilies P; Leblanc E; Tavassoli P; Kanaan N; Frewin K; Singh K; Adomat H; Böhm KJ; Prinz H; Guns ET; Rennie PS; Cherkasov A
Mol Cancer Ther; 2013 Nov; 12(11):2425-35. PubMed ID: 23939374
[TBL] [Abstract][Full Text] [Related]
38. Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents.
Xu X; Ge R; Li L; Wang J; Lu X; Xue S; Chen X; Li Z; Bian J
Eur J Med Chem; 2018 Jan; 143():1325-1344. PubMed ID: 29117897
[TBL] [Abstract][Full Text] [Related]
39. A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.
Andrieu T; Bertolini R; Nichols SE; Setoud R; Frey FJ; Baker ME; Frey BM
Biochem Pharmacol; 2011 Dec; 82(11):1651-62. PubMed ID: 21907706
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists.
Yamamoto S; Tomita N; Suzuki Y; Suzaki T; Kaku T; Hara T; Yamaoka M; Kanzaki N; Hasuoka A; Baba A; Ito M
Bioorg Med Chem; 2012 Apr; 20(7):2338-52. PubMed ID: 22391033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
